GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amrutanjan Health Care Ltd (NSE:AMRUTANJAN) » Definitions » EV-to-EBIT

Amrutanjan Health Care (NSE:AMRUTANJAN) EV-to-EBIT : 27.12 (As of Jun. 03, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Amrutanjan Health Care EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Amrutanjan Health Care's Enterprise Value is ₹18,805 Mil. Amrutanjan Health Care's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₹694 Mil. Therefore, Amrutanjan Health Care's EV-to-EBIT for today is 27.12.

The historical rank and industry rank for Amrutanjan Health Care's EV-to-EBIT or its related term are showing as below:

NSE:AMRUTANJAN' s EV-to-EBIT Range Over the Past 10 Years
Min: 16.5   Med: 28.6   Max: 82.25
Current: 27.11

During the past 13 years, the highest EV-to-EBIT of Amrutanjan Health Care was 82.25. The lowest was 16.50. And the median was 28.60.

NSE:AMRUTANJAN's EV-to-EBIT is ranked worse than
70.49% of 688 companies
in the Drug Manufacturers industry
Industry Median: 16.965 vs NSE:AMRUTANJAN: 27.11

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Amrutanjan Health Care's Enterprise Value for the quarter that ended in Mar. 2025 was ₹16,872 Mil. Amrutanjan Health Care's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₹694 Mil. Amrutanjan Health Care's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 was 4.11%.


Amrutanjan Health Care EV-to-EBIT Historical Data

The historical data trend for Amrutanjan Health Care's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amrutanjan Health Care EV-to-EBIT Chart

Amrutanjan Health Care Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.05 23.24 27.71 25.42 24.03

Amrutanjan Health Care Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.42 36.55 32.37 30.56 24.03

Competitive Comparison of Amrutanjan Health Care's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Amrutanjan Health Care's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amrutanjan Health Care's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amrutanjan Health Care's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Amrutanjan Health Care's EV-to-EBIT falls into.


;
;

Amrutanjan Health Care EV-to-EBIT Calculation

Amrutanjan Health Care's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=18805.248/693.532
=27.12

Amrutanjan Health Care's current Enterprise Value is ₹18,805 Mil.
Amrutanjan Health Care's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹694 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amrutanjan Health Care  (NSE:AMRUTANJAN) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Amrutanjan Health Care's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2025 ) =EBIT / Enterprise Value (Q: Mar. 2025 )
=693.532/16871.8978
=4.11 %

Amrutanjan Health Care's Enterprise Value for the quarter that ended in Mar. 2025 was ₹16,872 Mil.
Amrutanjan Health Care's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹694 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amrutanjan Health Care EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Amrutanjan Health Care's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Amrutanjan Health Care Business Description

Traded in Other Exchanges
Address
No. 103 (Old No. 42-45), Luz Church Road, Mylapore, Chennai, TN, IND, 600 004
Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkins, and inhalers. Geographically, it generates the majority of the revenue from India.

Amrutanjan Health Care Headlines

No Headlines